Abstract:Background Tumor metastasis is a major factor for poor prognosis of hepatocellular carcinoma (HCC), but the relationship between ubiquitination and metastasis need to be studied more systematically. We analyzed the ubiquitinome of HCC in this study to have a more comprehensive insight into human HCC metastasis. Methods The protein ubiquitination levels in 15 HCC specimens with vascular invasion and 15 without vascular invasion were detected by ubiquitinome. Proteins with significantly different ubiquitination levels between HCCs with and without vascular invasion were used to predict E3 ubiquitin ligases associated with tumor metastasis. The topological network of protein substrates and corresponding E3 ubiquitin ligases was constructed to identify the key E3 ubiquitin ligase. Besides, the growth, migration and invasion ability of LM3 and HUH7 hepatoma cell lines with and without SYVN1 expression interference were measured by cell proliferation assay, subcutaneous tumor assay, umphal vein endothelium tube formation assay, transwell migration and invasion assays. Finally, the interacting proteins of SYVN1 were screened and verified by protein interaction omics, immunofluorescence, and immunoprecipitation. Ubiquitin levels of related protein substrates in LM3 and HUH7 cells were compared in negative control, SYVN1 knockdown, and SYVN1 overexpression groups. Results In this study, our whole-cell proteomic dataset and ubiquitinomic dataset contained approximately 5600 proteins and 12,000 ubiquitinated sites. We discovered increased ubiquitinated sites with shorter ubiquitin chains during the progression of HCC metastasis. In addition, proteomic and ubiquitinomic analyses revealed that high expression of E3 ubiquitin-protein ligase SYVN1 is related with tumor metastasis. Furthermore, we found that SYVN1 interacted with heat shock protein 90 (HSP90) and impacted the ubiquitination of eukaryotic elongation factor 2 kinase (EEF2K). Conclusions The ubiquitination profiles of HCC with and without vascular invasion were significantly different. SYVN1 was the most important E3 ubiquitin-protein ligase responsible for this phenomenon, and it was related with tumor metastasis and growth. Therefore, SYVN1 might be a potential therapeutic target for HCC.

VHL suppresses UBE3B-mediated breast tumor growth and metastasis

UBE3B promotes breast cancer progression by antagonizing HIF-2α degradation

Ubiquitin/SUMO Modification Regulates VHL Protein Stability and Nucleocytoplasmic Localization.

Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis

VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation

WSB1 Promotes Tumor Metastasis by Inducing Pvhl Degradation

Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma

PIN1 and CDK1 Cooperatively Govern Pvhl Stability and Suppressive Functions

Clinical Significance of the Ubiquitin Ligase UBE3C in Hepatocellular Carcinoma Revealed by Exome Sequencing.

USP9X destabilizes pVHL and promotes cell proliferation.

Pvhl Acts As a Downstream Target of E2F1 to Suppress E2F1 Activity.

UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL

UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer

VHL governs m6A modification and PIK3R3 mRNA stability in clear cell renal cell carcinomas

Regulation Of P53 Level By Ube4b In Breast Cancer

Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma

Identification of anti-tumoral feedback loop between VHLα and hnRNPA2B1 in renal cancer

Phosphorylation-dependent Cleavage Regulates Von Hippel Lindau Proteostasis and Function.

Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy

High VHL Expression Reverses Warburg Phenotype and Enhances Immunogenicity in Kidney Tumor Cells

Hsp90 chaperone code and the tumor suppressor VHL cooperatively regulate the mitotic checkpoint